von Finck M, Eulert J, Heller W, Sohorer R
Anaesthesist. 1985 Dec;34(12):675-80.
With the current day implementation of methods of autotransfusion one retransfuses if possible only washed red cell concentrates and eliminates the plasma. In the case of operations where patients undergo large blood loss, one must effect a substitution for the lost plasma volume and the lost clotting factors. In addition to electrolyte and colloidal solutions one can use a substitution of homologous and also autologous fresh frozen plasma (FFP). The effects of different substitutes on the clotting reaction has been investigated in 47 patients on whom extensive orthopaedic and also traumatologic surgical operations have been performed. By the combination of homologous blood and homologous FFP as also with autologous red cells and homologous FFP the clotting reactions remain the same. This determines the advantages of autotransfusion as compared with conventional techniques but, in addition, there is a saving in the usage of homologous blood. Where an operation can be planned in advance, the necessary FFP can be obtained from the patient. By utilisation of autologous FFP the operative and post- operative blood losses are reduced. As a result it is possible e.g. in total hip prosthesis, in approximately 90% of all cases, to operate without using homologous blood or plasma. The determined stability of AT III in autologous plasma--without AT III prophylaxis of thrombosis by Heparin is ineffective--and all other clotting factors leads to an expectancy of a not activated clotting mechanism and at the same time to low thrombosis risks.(ABSTRACT TRUNCATED AT 250 WORDS)
随着当前自体输血方法的实施,如果可能的话,仅回输洗涤红细胞浓缩物并去除血浆。在患者失血量大的手术中,必须补充丢失的血浆量和凝血因子。除了电解质溶液和胶体溶液外,还可以使用同种异体和自体新鲜冰冻血浆(FFP)进行替代。对47例接受广泛骨科和创伤外科手术的患者研究了不同替代物对凝血反应的影响。通过将同种异体血与同种异体FFP以及自体红细胞与同种异体FFP联合使用,凝血反应保持不变。这决定了自体输血相对于传统技术的优势,此外,还节省了同种异体血的使用。如果手术可以提前计划,可以从患者身上获取所需的FFP。通过使用自体FFP,手术中和术后的失血量减少。因此,例如在全髋关节置换术中,大约90%的病例可以在不使用同种异体血或血浆的情况下进行手术。在自体血浆中确定的抗凝血酶III(AT III)稳定性——在不使用肝素预防血栓形成的情况下,AT III无效——以及所有其他凝血因子导致预期凝血机制未激活,同时血栓形成风险较低。(摘要截断于250字)